Dysport®, the first competitor to Botox®
After more than 10 years of use in Europe and several years of testing here in the United States, Dysport gained FDA clearance for the treatment of lines between the eyebrows in 2009. This is the same clearance under which Botox and Xeomin are used to treat wrinkles and lines.
How Dysport Different from Injectable Fillers
Some people are still not entirely clear on the differences between muscle relaxing drugs such as Botox, Dysport and Xeomin and injectable fillers. Briefly, Botox, Dysport and Xeomin are used to relax facial muscles to accomplish one of two possible objectives: diminish the depth of wrinkles and lines caused by repeated action of the muscles (e.g. between the eyebrows, in the forehead, or at the corner of the eyes) or recontour the face by lifting the brows, correcting downturned corners of the mouth, soften the jawline, etc. In contrast, injectable fillers are used to fill in some facial lines and depressions and, perhaps more importantly, to correct the thinning and sagging that occurs in our faces as we age.
How Dysport Is Different from Botox and Xeomin
Dysport, like Botox and Xeomin, is a form of botulinum toxin. Although chemically the drugs are not identical, all three are administered via injection using a tiny needle. Some believe that Dysport has a slightly faster onset of effect than Botox and Xeomin but this has not been proven scientifically. However, if you find yourself short on time before a party or event, Dysport may be the best choice. Dysport also spreads differently after it has been injected and, consequently, in some areas such as the “crows feet” region or in a tall forehead, may produce a softer, more diffuse effect than Botox or Xeomin. The duration of effect of all three neuromodulators s typically several months. Some investigators feel that Dysport generally lasts a bit longer than Botox but this has not yet been proven scientifically. Dysport Botox, and Xeomin are priced similarly.
Are any new Drugs Similar to Dysport Expected to be on the Market in the Future?
Dysport has become a mainstay in the neuromodulator market in the United States. Several other similar products (all botulinum drugs) are in the pipeline and will likely arrive in the US within the foreseeable future. While all are similar, each product has its nuances and subtle differences. We will continue to provide you with accurate and “hype-free” information about these products as it becomes available.